Tag: biopharma
Beyond Trade: How the EU–India FTA reshapes life-sciences industry
The deal represents nearly 25% of global GDP and one-third of global trade, making it one of the most consequential trade agreements of this era
Zydus launches Tishtha, the world’s first biosimilar of Nivolumab, in India...
The immunotherapy reduces treatment burden by making it accessible at approximately 1/4th cost of the reference drug
Sentynl Therapeutics announces FDA approval of ZYCUBO
Now the first and only therapy approved for the treatment of Menkes disease in the United States
Aragen launches CHOMax™ reducing DNA to clinical supply to 10 months
Integrated cell line development, process development, analytics, GMP drug substance, plus drug product support through qualified partners
Bharat Biotech’s Nucelion collaborates with Pandorum Technologies to advance exosome-driven tissue...
By leveraging Nucelion Therapeutics’ manufacturing capabilities, the partnership supports regional supply and regulatory readiness, marking a strategic step forward
Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for...
The agreement strengthens Lupin’s diabetes portfolio and accelerates its presence in the obesity segment
Pharma industry leaders spotlight quality, sustainability & market diversification as export...
Indian Pharmacopoeia reinforced as a critical pillar of international credibility, reflecting India’s scientific rigour and regulatory maturity
Biopharma enters 2026 with renewed and cautious optimism, says GlobalData
As per the report’s survey, 52% of pharmaceutical professionals felt optimistic or very optimistic about the industry’s growth in 2026, which is up by 10% compared to data gathered six months ago
Avantor appoints Gladys Wang as Vice President, Bioprocessing Commercial, Asia, Middle...
Gladys, based in Singapore, has extensive experience collaborating with biopharma manufacturers, contract development and manufacturing organizations (CDMOs), and key opinion leaders
SVKM’s NMIMS earns three honours at Indian Pharmaceutical Congress 2025
Event brought together academicians, researchers, and industry professionals from India and abroad to discuss how technology is influencing drug development, quality assurance, and healthcare delivery